Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A molecular perspective of CTLA-4 function.

Wendy A Teft1, Mark G Kirchhof, Joaquín Madrenas

  • 1The FOCIS Center for Clinical Immunology and Immunotherapeutics, Robarts Research Institute, and Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada, N6A 5K8.

Annual Review of Immunology
|March 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Features, Psychiatric Comorbidities, and Treatment Outcomes in Dermatitis Artefacta: A Systematic Review.

Journal of cutaneous medicine and surgery·2026
Same author

Upadacitinib for the treatment of geographic tongue: A case report.

JAAD case reports·2026
Same author

Differential Expression of Endocannabinoid Receptors in Lesional and Non-Lesional Skin of Psoriasis Patients: Insights Into Pathogenesis and Potential Therapeutic Targets.

Journal of cutaneous medicine and surgery·2026
Same author

Distribution of Cytokines and Their Receptors Targeted by Biologics in the Treatment of Psoriasis.

Journal of cutaneous medicine and surgery·2026
Same author

Response to Reader Comment on: Navigating Bullous Pemphigoid: Consensus Recommendations for Diagnosis and Management-A Canadian Perspective.

Journal of cutaneous medicine and surgery·2025
Same author

Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison.

Dermatology and therapy·2025
Same journal

The Neuroimmune Circuitry of Peripheral Sensory Neuron Subtypes in Chronic Pain.

Annual review of immunology·2026
Same journal

The Spectrum of Fibroblast Immune Biology.

Annual review of immunology·2026
Same journal

The Molecular Logic of Immunoglobulin Heavy Chain Class Switch Recombination.

Annual review of immunology·2026
Same journal

Decoding Human T Cell Immunity with Artificial Intelligence and Single-Cell Genomics.

Annual review of immunology·2026
Same journal

Immune Niches in Cancer.

Annual review of immunology·2026
Same journal

T Cell Receptor Signaling and Immune Tolerance: From Autoimmunity to Cancer Immunity.

Annual review of immunology·2026
See all related articles

Investigating the structural features of cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), a key regulator of T cell responses, can help develop new immunotherapies. Understanding CTLA-4

Area of Science:

  • Immunology
  • Molecular Biology
  • T cell Activation

Background:

  • The two-signal model of lymphocyte activation highlights the importance of costimulatory molecules.
  • Numerous costimulatory molecules, including inhibitory ones, have been identified, showing therapeutic potential.
  • Targeting inhibitory costimulatory molecules, like CTLA-4, for therapeutic modulation remains challenging.

Purpose of the Study:

  • To explore the physiological implications of the structural features of cytotoxic T lymphocyte-associated antigen-4 (CTLA-4).
  • To provide insights that may aid in designing novel immunotherapeutic agents targeting CTLA-4.

Main Methods:

  • Review and analysis of existing literature on CTLA-4 structure and function.
  • Focus on the physiological relevance of CTLA-4's structural characteristics.

Related Experiment Videos

Main Results:

  • CTLA-4 is a major negative regulator of T cell responses.
  • Understanding CTLA-4's structure is crucial for its therapeutic targeting.

Conclusions:

  • The structural features of CTLA-4 hold significant physiological implications for T cell regulation.
  • Further investigation into CTLA-4's structure can facilitate the development of effective CTLA-4-targeted immunotherapies.